Opiant Pharmaceuticals Inc (OPNT) Stock
OPNT is no longer traded. Opiant Pharmaceuticals was delisted from the Nasdaq in March 2023.
Prices on this page are historical; the last trade was March 1, 2023 at $20.65.
Opiant Pharmaceuticals stock price history
OPNT final trading statistics
- Final close
- $20.65
- Final trading day
- Mar 1, 2023
- Market cap at delisting
- $108.80M
- Shares outstanding
- 5.27M
- Final 52-week range
- $7.34 – $29.25
- Avg. volume (final 3 mo.)
- 83,622
- All-time high (split-adj.)
- $128.00 · Dec 2009
- All-time low (split-adj.)
- $1.80 · Jun 2013
- Return since IPO
- -82.8%
- Beta
- 0.83
- Book value / share
- $3.97
- Price / book
- 5.20
Opiant Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $40.73M | $3.0M | -$4.07 |
| FY2021 | $27.40M | -$1.9M | -$0.36 |
| FY2020 | $38.24M | $11.6M | $1.72 |
| FY2019 | $13.51M | -$21.2M | -$0.82 |
| FY2018 | $13.98M | -$21.2M | -$3.76 |
Last five fiscal years reported before the delisting; fiscal year ending July. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Opiant Pharmaceuticals Inc
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.
Opiant Pharmaceuticals stock FAQ
What happened to Opiant Pharmaceuticals stock?
Opiant Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $20.65 on March 1, 2023.
Is OPNT stock still trading?
No. OPNT was delisted from the Nasdaq in March 2023 and no longer trades on a U.S. exchange.
What was the last price of OPNT stock?
OPNT closed at $20.65 on its final trading day, March 1, 2023, for a market value of about $108.80M.
What were Opiant Pharmaceuticals's revenue and earnings in its last full fiscal year?
Opiant Pharmaceuticals reported revenue of $40.73M and net income of $3.0M in fiscal 2022, its last full year as a public company.
When did Opiant Pharmaceuticals go public?
Opiant Pharmaceuticals Inc stock began trading on January 4, 2016.